Breaking News2 years ago
Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim Result
[ad_1] By Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney disease nephropathy...
